Overview

Multiple-loading Dose Regimen Study in Patients With Chronic Plaque-type Psoriasis

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
Loading dose, four arm, double-blind, parallel group, placebo-controlled study comparing single and multiple doses of AIN457 to placebo in patients with a diagnosis of moderate to severe chronic plaque psoriasis.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis Pharmaceuticals